Patients with treatment‐resistant depression who received a series of treatments with ketamine or esketamine showed a substantial reduction in emergency department visits related to suicidality over a 6‐month period, a study has found. Study participants had a 56.7% response rate of depression symptoms following the acute phase of treatment.
Building similarity graph...
Analyzing shared references across papers
Loading...
A Wed, study studied this question.
www.synapsesocial.com/papers/69d895be6c1944d70ce06e42 — DOI: https://doi.org/10.1002/pu.31440
The Brown University Psychopharmacology Update
Building similarity graph...
Analyzing shared references across papers
Loading...